glpfaq.com is a community forum and reference resource for people using or considering GLP-1 medications (semaglutide, tirzepatide, liraglutide, retatrutide, and related drugs sold under names including Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda). This page describes how we write the long-form articles on this site, so you can decide how much weight to give them.
A peer-support community with an editorial team that writes reference articles based on the questions our members ask most often. We are not a clinical site, a pharmacy, or a medical practice. Nobody on our editorial team is a licensed physician or nurse practitioner. We do not prescribe, diagnose, or treat.
Our reference articles aggregate and summarize patterns from:
When an article references an over-the-counter product's dosage, we quote the FDA label directly and link to it. We do not invent or modify dosing recommendations.
Editorial Lead: MetabolicMindset. A long-term forum member who began contributing editorial summaries after documenting their own GLP-1 journey. Day-to-day editing is shared across our small editorial team; significant articles carry an explicit byline at the article level.
1. Drafting: Our editorial team outlines an article based on common member questions, then drafts it against our cited sources.
2. Editorial review: A team editor checks every draft for factual accuracy against the cited sources, removes anything not supported by those sources, and adds safety caveats.
3. Methodology disclosure: When an article presents community-reported outcomes (e.g., "members who tried X reported Y"), we link to a methodology note explaining how we counted posts, what time range we looked at, and what we excluded.
4. Corrections: If a reader or a clinician identifies an error, we correct it and add a "Correction" note at the bottom of the article. Significant changes get a new "Last updated" date.
We do not currently employ a licensed medical reviewer. Articles on this site are editorially reviewed by our team — not medically reviewed. If and when we add a licensed reviewer, articles they have signed off on will clearly display the reviewer's name, credential, state license number, and the date of review.
Do not treat editorially-reviewed articles as a substitute for advice from a licensed healthcare provider.
glpfaq.com is a business. We plan to monetize through advertising and vendor sponsorships (see our Terms of Service). To keep editorial integrity while doing this:
If you compare any article on this site against Mayo Clinic, Cleveland Clinic, or the FDA's own patient-information pages, you should give weight to those over us on any matter of clinical fact. What we offer that they do not is pattern aggregation from real patients — what people actually experienced, what they tried, what worked for many of them and what did not. That is complementary, not a substitute.